These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25015681)

  • 1. The utility of ADMIRE-HF risk score in predicting serious arrhythmic events in heart failure patients: incremental prognostic benefit of cardiac 123I-mIBG scintigraphy.
    Al Badarin FJ; Wimmer AP; Kennedy KF; Jacobson AF; Bateman TM
    J Nucl Cardiol; 2014 Aug; 21(4):756-62; quiz 753-55, 763-5. PubMed ID: 25015681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of cardiac
    De Vincentis G; Frantellizzi V; Fedele F; Farcomeni A; Scarparo P; Salvi N; Fegatelli DA; Mancone M; Verschure DO; Verberne HJ
    J Nucl Cardiol; 2019 Aug; 26(4):1188-1196. PubMed ID: 29594915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of ejection fraction on the prognostic value of sympathetic innervation imaging with iodine-123 MIBG in heart failure.
    Shah AM; Bourgoun M; Narula J; Jacobson AF; Solomon SD
    JACC Cardiovasc Imaging; 2012 Nov; 5(11):1139-46. PubMed ID: 23153914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study.
    Jacobson AF; Senior R; Cerqueira MD; Wong ND; Thomas GS; Lopez VA; Agostini D; Weiland F; Chandna H; Narula J;
    J Am Coll Cardiol; 2010 May; 55(20):2212-21. PubMed ID: 20188504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting Risk Versus Predicting Potential Survival Benefit Using 123I-mIBG Imaging in Patients With Systolic Dysfunction Eligible for Implantable Cardiac Defibrillator Implantation: Analysis of Data From the Prospective ADMIRE-HF Study.
    Hachamovitch R; Nutter B; Menon V; Cerqueira MD
    Circ Cardiovasc Imaging; 2015 Dec; 8(12):. PubMed ID: 26666380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incremental prognostic value of myocardial neuroadrenergic damage in patients with chronic congestive heart failure: An iodine-123 meta-iodobenzylguanidine scintigraphy study.
    Giovanni S; Stefano M; Teresa SM; Margherita C; Giovanni B; Umberto P; Paola P; Giacomo C; Pierfranco D; Alfonso G; Riccardo C; Claudio M
    J Nucl Cardiol; 2020 Oct; 27(5):1787-1797. PubMed ID: 30377997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simplified wall-based model for regional innervation/perfusion mismatch assessed by cardiac 123I-mIBG and rest 99mTc-tetrofosmin SPECT to predict arrhythmic events in ischaemic heart failure.
    Verschure DO; Poel E; Travin MI; Henzlova MJ; Jain D; Jacobson AF; Verberne HJ
    Eur Heart J Cardiovasc Imaging; 2022 Aug; 23(9):1201-1209. PubMed ID: 34427293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac sympathetic innervation assessed with (123)I-MIBG retains prognostic utility in diabetic patients with severe left ventricular dysfunction evaluated for primary prevention implantable cardioverter-defibrillator.
    García-González P; Fabregat-Andrés Ó; Cozar-Santiago P; Sánchez-Jurado R; Estornell-Erill J; Valle-Muñoz A; Quesada-Dorador A; Payá-Serrano R; Ferrer-Rebolleda J; Ridocci-Soriano F
    Rev Esp Med Nucl Imagen Mol; 2016; 35(2):74-80. PubMed ID: 26514320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early echocardiographic deformation analysis for the prediction of sudden cardiac death and life-threatening arrhythmias after myocardial infarction.
    Ersbøll M; Valeur N; Andersen MJ; Mogensen UM; Vinther M; Svendsen JH; Møller JE; Kisslo J; Velazquez EJ; Hassager C; Søgaard P; Køber L
    JACC Cardiovasc Imaging; 2013 Aug; 6(8):851-60. PubMed ID: 23850252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resting perfusion MPI-SPECT combined with cardiac 123I-mIBG sympathetic innervation imaging improves prediction of arrhythmic events in non-ischemic cardiomyopathy patients: sub-study from the ADMIRE-HF trial.
    Sood N; Al Badarin F; Parker M; Pullatt R; Jacobson AF; Bateman TM; Heller GV
    J Nucl Cardiol; 2013 Oct; 20(5):813-20. PubMed ID: 23864400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac
    Verschure DO; de Groot JR; Mirzaei S; Gheysens O; Nakajima K; van Eck-Smit BLF; Aernout Somsen G; Verberne HJ
    Int J Cardiol; 2017 Dec; 248():403-408. PubMed ID: 28847545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of sudden cardiac death in chronic heart failure patients with reduced ejection fraction by ADMIRE-HF risk score and early repolarization pattern.
    Ikeda-Yorifuji I; Yamada T; Tamaki S; Morita T; Furukawa Y; Iwasaki Y; Kawasaki M; Kikuchi A; Kawai T; Seo M; Fukuhara E; Abe M; Nakamura J; Fukunami M
    J Nucl Cardiol; 2020 Jun; 27(3):992-1001. PubMed ID: 30761485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting the need for an implantable cardioverter defibrillator using cardiac metaiodobenzylguanidine activity together with plasma natriuretic peptide concentration or left ventricular function.
    Nagahara D; Nakata T; Hashimoto A; Wakabayashi T; Kyuma M; Noda R; Shimoshige S; Uno K; Tsuchihashi K; Shimamoto K
    J Nucl Med; 2008 Feb; 49(2):225-33. PubMed ID: 18199625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pooled analysis of multicenter cohort studies of (123)I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure.
    Nakata T; Nakajima K; Yamashina S; Yamada T; Momose M; Kasama S; Matsui T; Matsuo S; Travin MI; Jacobson AF
    JACC Cardiovasc Imaging; 2013 Jul; 6(7):772-84. PubMed ID: 23845574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients.
    Boogers MJ; Borleffs CJ; Henneman MM; van Bommel RJ; van Ramshorst J; Boersma E; Dibbets-Schneider P; Stokkel MP; van der Wall EE; Schalij MJ; Bax JJ
    J Am Coll Cardiol; 2010 Jun; 55(24):2769-77. PubMed ID: 20538172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac 123I-MIBG Imaging for Clinical Decision Making: 22-Year Experience in Japan.
    Nakajima K; Nakata T
    J Nucl Med; 2015 Jun; 56 Suppl 4():11S-19S. PubMed ID: 26033897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ¹²³I-MIBG Imaging for Prediction of Mortality and Potentially Fatal Events in Heart Failure: The ADMIRE-HFX Study.
    Narula J; Gerson M; Thomas GS; Cerqueira MD; Jacobson AF
    J Nucl Med; 2015 Jul; 56(7):1011-8. PubMed ID: 26069309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic usefulness of planar
    Agostini D; Ananthasubramaniam K; Chandna H; Friberg L; Hudnut A; Koren M; Miyamoto MI; Senior R; Shah M; Travin MI; Dahl JV; Chen K; Levy WC;
    J Nucl Cardiol; 2021 Aug; 28(4):1490-1503. PubMed ID: 31468379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality and utility of [
    Teresińska A; Woźniak O; Maciąg A; Wnuk J; Jezierski J; Fronczak A; Biernacka EK
    Ann Nucl Med; 2021 Aug; 35(8):916-926. PubMed ID: 34023989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac iodine-123 metaiodobenzylguanidine imaging predicts ventricular arrhythmia in heart failure patients receiving an implantable cardioverter-defibrillator for primary prevention.
    Marshall A; Cheetham A; George RS; Mason M; Kelion AD
    Heart; 2012 Sep; 98(18):1359-65. PubMed ID: 22904144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.